IL-8/CXCR2 autocrine signaling also contributes to the angiogenic and metastatic phenotype of RCC cells, but may be of lesser importance as a therapeutic tool, although its targeting might augment the therapeutic benefit gained from SOCS-3 modulation and IFN-α treatment. The gene discussed is CXCL8; the disease is renal cell carcinoma.